China-Swiss collaboration to push forward ethical use of AI technology in healthcare

image credits: shutterstock

QingSong Health, a leading health technology platform based in China, has announced a strategic partnership with Globethics, a leading organisation on ethical leadership based in Geneva, Switzerland. This collaboration is set to push forward the ethical use of artificial intelligence (AI) technology in healthcare, promote education on philanthropic ethics, and enhance global collaboration on AI ethics.

QingSong Health has made significant strides in the health insurance sector with its innovative technology and business model. The company provides comprehensive health services, including health insurance, medical services, and health-related charity work, ensuring full-spectrum care from prevention and treatment to recovery.

Globethics has a special consultative status with the Economic and Social Council of the United Nations (ECOSOC) and official cooperation with the UN World Summit of Informationa Society (WSIS), World Health Organization (WHO), and United Nations Educational, Scientific and Cultural Organization (UNESCO). Founded in 2004, this Geneva-based foundation is dedicated to ethical governance and leadership through education, policy dialogue, and public engagement.

The partnership will mainly focus on the ethical application of AI technology in healthcare. Together, QingSong Health and Globethics will develop ethical guidelines for AI use in medical contexts, establishing clear standards for data collection, processing, and usage to ensure compliance with ethical principles. They will also create mechanisms for regular evaluation and review of AI applications to identify and mitigate potential ethical risks.